An epidemiOlogy study to deteRmine the prevalence of EGFR (Epidermal growth factor receptor) muTations in RUSsian patients with advanced NSCLC (Non-Small Cell Lung Cancer). - ORTUS

Study identifier:D133FR00101

ClinicalTrials.gov identifier:NCT02321046

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An epidemiOlogy study to deteRmine the prevalence of EGFR muTations in RUSsian patients with advanced NSCLC (ORTUS)

Medical condition

Non-small Cell Lung Cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

26

Study type

Observational

Age

N/A

Date

Study Start Date: 02 Sept 2015
Primary Completion Date: 28 Jun 2019
Study Completion Date: 28 Jun 2019

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2020 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria